Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Georg Nölker , Dieter Horstkotte , Klaus-Jürgen Gutleben Added: 3 years ago
Catheter ablation is an established treatment option for patients with symptomatic atrial fibrillation (AF).1-3 Pulmonary vein (PV) angiography has been the initial imaging tool in AF ablation and is still used by up to 50 % of leading electrophysiologists.3 PV angiography still plays a major role in balloon-based ablation techniques routinely performed without electroanatomical mapping (EAM)… View more
Author(s): Tom JR De Potter , Gazmend Bardhaj , Aniello Viggiano , et al Added: 3 years ago
Percutaneous catheter treatment for atrial fibrillation (AF) has seen an exponential uptake since the first cases were published exactly two decades ago.1 Evolving over different approaches and treatment strategies, current standard of care consists of pulmonary vein isolation (PVI) through radiofrequency (RF) or other energy sources. While this treatment has been shown to be superior to… View more
Author(s): Saagar Mahida , Benjamin Berte , Seigo Yamashita , et al Added: 3 years ago
Since the first catheter ablation for cardiac arrhythmia more than three decades ago, ablation technology has continually evolved at a rapid pace. Much of the early progress in the field was made in ablation of supraventricular tachycardias. Following a seminal study from Haïssaguerre et al.1 in 1998, which demonstrated that pulmonary vein triggers are important sources of atrial fibrillation (AF… View more
Author(s): Michael Ghannam , Hakan Oral Added: 3 years ago
Maintenance of sinus rhythm in patients with non-paroxysmal AF is often challenging and complex. Catheter ablation is usually superior to anti-arrhythmic drug therapy alone. However, recurrence rates are high and have remained suboptimal. Although pulmonary vein isolation (PVI) is usually effective in treating paroxysmal AF, it is not sufficient for many patients with non-paroxysmal AF,… View more
Author(s): Tina Baykaner , Junaid AB Zaman , Paul J Wang , et al Added: 3 years ago
Treatment of atrial fibrillation (AF) classically focuses on eliminating triggers near and from the pulmonary veins, which may initiate AF. However, the 1–2 year success rate of pulmonary vein isolation (PVI) remains 40–50% for persistent AF1,2 and 50–65% for paroxysmal AF,3–5 while supplementary linear lesions or extensive ablation at electrogram-targets have had disappointing results and may… View more
Job title: Interventional Cardiologist
Dr Robert Garbo has been an Interventional Cardiologist since 1999. He was Head of the Cath Lab at San Giovanni Bosco Hospital from2005- 2020, director of the CTO PCI, CHIP, and complex PCI programs over the last 15 years. He has operated more than 2200 CTO PCI, of which 1100 with retrogradeapproach. Proctor for CTO PCI programs in Italy, Europe( France, Poland, Romania, Czeck republic,… View more
Research Area(s) / Expertise:

Hypertension

Job title: Consultant Cardiologist
Dr Smith qualified in 1994 from Guy’s and St Thomas’ Hospitals, London. He trained in general & interventional cardiology at the Manchester Heart Centre (Manchester Royal Infirmary) and The London Chest Hospital. Dr Smith was appointed as a consultant in 2008 and works at Barts Heart Centre (Barts Health NHS Trust) and Royal Free Hospitals Foundation Trust as an interventional Cardiologist. He… View more
Job title: Head of Invasive Cardiology (Invasve Cardiology)
Invasive Cardiologist and Angiologist at University of Szeged, Internal Medicine Department and at Semmelweis University, Cardiac and Vascular Center. Head of Invasive Cardiology and Angiology at University of Szeged, Internal Medicine Department. Past president of the Hungarian Association of Cardio-Vascular Interventions. He is expert in doing complex coronary (CTO, LM, rotational atherectomy)… View more